Ohr Pharmaceutical Regains Compliance with NASDAQ Listing Requirements

NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. OHRP today announced that it received notice from The Nasdaq Stock Market LLC indicating that the Company has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) (the "Bid Price Rule") for continued listing on The NASDAQ Capital Market. Accordingly, the Company has regained compliance with the Bid Price Rule and NASDAQ considers the matter closed.

Ohr Pharmaceutical Contact:

Investor Relations                                         

OP: 212-682-8452

ir@ohrpharmaceutical.com

ohrlogo.jpg

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MarketsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!